Strain Summary[not specified]-E2f3tm5(E2f1)Gle/? Speer6-ps1Tg(Alb-cre)21Mgn/?
Strain Name |
[not specified]-E2f3tm5(E2f1)Gle/? Speer6-ps1Tg(Alb-cre)21Mgn/? |
Strain Type(s) |
targeted mutation (knock-in) • transgenic |
Strain Synonym(s) |
Alb 3a1KI/+ or 1KI/1KI • Alb-Cre 3a1KI/+ or Alb-Cre 3a1KI/1KI • Alb E2f3a1KI/+ or 1KI/1KI • [not specified]-E2f3tm5(E2f1)Gle/? Tg(Alb-cre)21Mgn |
Description |
Compound mutant mice. The genetic background of these mice was not specified but included FVB, 129, C57BL/Swiss, and possibly C57BL/6, DBA and/or other strain(s). |
Strain Genetics |
E2f3tm5(E2f1)Gle / E2f3? |
| Speer6-ps1Tg(Alb-cre)21Mgn / Speer6-ps1? |
| Frequency | ||||||||
|---|---|---|---|---|---|---|---|---|
| Model Name | Organ Affected | Tumor Inducing Agent(s) | Female | Male | Mixed Pop. | Unspecified | Additional Information | Model Details |
| Liver hepatocellular carcinoma | Liver |
0 |
0 |
References: Kent LN, J Clin Invest 2017 Mar 01;127(3):830-842 |
||||